Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
about
Progress and problems with the use of suicide genes for targeted cancer therapyRice Bran and Probiotics Alter the Porcine Large Intestine and Serum Metabolomes for Protection against Human Rotavirus DiarrheaIrinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons.Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy.Sacituzumab govitecan: an antibody-drug conjugate.Novel 20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent: a patent evaluation of WO2015048365 (A1).Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.Gefitinib enhances the antitumor activity of CPT-11 in vitro and in vivo by inhibiting ABCG2 but not ABCB1: a new clue to circumvent gastrointestinal toxicity risk.DNA topoisomerase-targeting chemotherapeutics: what's new?Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity.Prolonged Deleterious Influences of Chemotherapeutic Agent CPT-11 on Resident Peritoneal Macrophages and B1 Cells.The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues.
P2860
Q28262370-A7576246-27E7-4E7A-9246-D4FE8B321B27Q33586440-C3EB914B-BF28-4E27-9AC7-1CE4B38EE496Q33774788-C9772C11-350A-4365-A000-37F23125BE95Q37698616-467F17E3-AD79-46E3-9438-EC3FC5744465Q38683957-D698D8EB-F82A-4F54-A38C-37C4F8886421Q38799252-F328EFB2-4B07-46FB-8CAA-863045312E75Q38945299-BDB58988-7492-4683-A26B-BE79F2B323EAQ39031261-A57ABC0D-9AA5-4D7F-983F-3118A85F7E7CQ39320242-7B42F106-680F-4424-8B6C-7A438657383CQ41160069-3BB2D038-7F64-4044-8C2C-12294CE8ED3BQ47107453-6FBA78B9-A745-48C1-8317-DA99AA3F0818Q49467285-A300520C-1459-4DCC-ABCA-6369B80BDC21Q50054146-C6B95450-97EA-41D3-B472-99411F8E534E
P2860
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
@en
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
@nl
type
label
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
@en
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
@nl
prefLabel
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
@en
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
@nl
P2860
P1433
P1476
Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis
@en
P2093
Sanjay Goel
Sridhar Mani
P2860
P304
P356
10.2174/1389450111314070007
P50
P577
2013-06-01T00:00:00Z